Numerous studies have shown that phosphatase and tensin homolog (PTEN) mutations occur in CCA patients, and PTEN acts as a negative regulator of PI3K/AKT signaling pathway in CCA cells. The gene discussed is AKT1; the disease is cholangiocarcinoma.